Navigation Links
Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
Date:6/8/2009

elds that have a strong need for therapeutic innovation such as Alzheimer's disease, Parkinson's disease, tinnitus, chronic pain conditions, addictions, and neuromuscular disturbances.

Merz Pharmaceuticals, LLC is the wholly owned, US subsidiary of the Merz Group of Companies. A specialty pharmaceutical company, Merz Pharmaceuticals, LLC was established in 1995 and is responsible for the commercialization of Merz (KGAa) products in the US.


'/>"/>
SOURCE Merz Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
2. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
3. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
4. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
5. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
7. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
8. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
9. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
10. TRACON Pharmaceuticals Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
11. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015 Velos, Inc., the pioneering software ... grow and add customers who receive Clinical and Translational ... CTSAs awarded by the National Institutes of Health currently ... is among the largest such market shares in its ... CTSA community keeps growing as a result of our ...
(Date:6/30/2015)... , June 30, 2015   Millar, Inc. ... technology, today announced the 2016 retirement of Craig ... Directors, after 12 years of service to the Company. ... named two senior members of the Executive Management team ... Tim Daugherty , currently Director of Sales and ...
(Date:6/30/2015)... , June 30, 2015 Olympus, ... innovative solutions for medical and surgical procedures, among ... next-day replacements for surgical equipment at no additional ... to offer this type of guarantee. The service ... Service Agreement earlier this year. ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... 7, 2010 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Review meeting with the U.S. Food and Drug Administration (FDA) ... the Company,s New Drug Application (NDA) for AZ-004 ( Staccato ... FDA in preparation for the meeting, with the responses or ...
... Dec. 7, 2010 Apexigen, Inc. announced today ... worldwide license agreement with Centocor Research & Development, ... therapeutic antibody technologies to discover and develop monoclonal ... to several targets specified by Centocor R&D, which ...
Cached Medicine Technology:Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 2Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 3Apexigen, Inc. Announces Collaboration for Antibody Discovery 2
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable source of ... native of Detroit, MI, Kid Rock, is hitting the road again this summer in what ... and hip hop superstar kicked off his summer tour this year at the XFINITY Theatre ...
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
Breaking Medicine News(10 mins):Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... ... at ITEXPO , ... CA, ITEXPO West 2009 (PRWEB) September 3, 2009 -- FaxBack®, a leading provider of ... program for a new fax ATA device, based on HTTPS, which provides a superior level ...
... ... , ... September 3, 2009 -- Today,s challenging business environment requires companies to maximize valuable resources ... staffs, the reliance on outside consultants to accomplish these strategies becomes not just a ...
... , , PHOENIX, Sept. 2 ... southwestern United States, has formed a strategic alliance with American National ... getting claims compensated in a timely manner with a proprietary process ... , , "Over the last 10 years ...
... MONTREAL, Sept. 2 With five years and ... manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of ... products nationwide in Canada with an exclusive multimillion-dollar agreement ... Patterson has operations in Vancouver, Edmonton, Calgary, London, Toronto, ...
... , , , ... Martek Biosciences Corporation (Nasdaq: MATK ) today announced its financial results ... $77.8 million, down 12% from $88.4 million in the third quarter of fiscal ... third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or ...
... , NEW YORK , Sept. 2 In the ... don,t have to shout to be heard. A pioneer in the eHealth ... online call for a careful, strategic approach to reform is attracting the ... as everyday Americans currently struggling to pay their medical bills. , ...
Cached Medicine News:Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 3Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Martek Announces Third Quarter 2009 Financial Results 2Health News:Martek Announces Third Quarter 2009 Financial Results 3Health News:Martek Announces Third Quarter 2009 Financial Results 4Health News:Martek Announces Third Quarter 2009 Financial Results 5Health News:Martek Announces Third Quarter 2009 Financial Results 6Health News:Martek Announces Third Quarter 2009 Financial Results 7Health News:Martek Announces Third Quarter 2009 Financial Results 8Health News:Martek Announces Third Quarter 2009 Financial Results 9Health News:Martek Announces Third Quarter 2009 Financial Results 10Health News:Martek Announces Third Quarter 2009 Financial Results 11Health News:Martek Announces Third Quarter 2009 Financial Results 12Health News:Healthcare Debate: One Citizen's Call for Calm Catches On 2
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: